The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Vitreoretinal Disorder Market Expected To Change Between 2026 And 2030?
The vitreoretinal disorder market has experienced substantial growth in recent years. It is projected to expand from $4.63 billion in 2025 to $4.99 billion in 2026, at a compound annual growth rate (CAGR) of 7.9%. The market’s historical growth can be attributed to the increasing prevalence of diabetic eye diseases, wider availability of optical coherence tomography, an increase in ophthalmic surgical procedures, the expansion of specialty eye clinics, and improved diagnostic accuracy.
The vitreoretinal disorder market size is projected to experience substantial expansion in the coming years. It is forecast to reach $6.71 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This growth during the forecast period is primarily driven by increasing demand for personalized retinal treatments, rising investments in ophthalmic innovation, the expansion of minimally invasive surgical techniques, the growing application of AI-driven diagnostics, and an increased focus on vision preservation therapies. Prominent trends anticipated in the forecast period encompass the rising adoption of advanced retinal imaging techniques, increased utilization of minimally invasive vitreoretinal surgery, greater integration of AI-based diagnostic tools, the broadening of targeted retinal therapies, and an intensified focus on early disease detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23574&type=smp
What Underlying Factors Are Accelerating The Growth Of The Vitreoretinal Disorder Market?
The increasing occurrence of diabetic retinopathy is projected to boost the expansion of the vitreoretinal disorder market in the future. This eye condition, diabetic retinopathy, results from damage to the retinal blood vessels, primarily due to elevated blood sugar in individuals with diabetes. Its incidence is on the rise, largely because of the growing prevalence of diabetes, which itself is fueled by inactive lifestyles and inadequate blood sugar management, leading to injury to the retinal blood vessels. Managing vitreoretinal disorders is vital for treating diabetic retinopathy, as it tackles complications like vitreous hemorrhage and tractional retinal detachment, thus safeguarding eyesight and averting additional harm to the retina. For example, data from October 2024, published by the Australian Institute of Health and Welfare, an Australia-based government body, indicated that in 2022–23, 1.8% of screened First Nations people in Australia underwent treatment for diabetic retinopathy. This group had an age-standardized treatment rate of 1.3%, which was lower than that of non-Indigenous Australians at 1.5%. Consequently, the increasing occurrence of diabetic retinopathy is propelling the expansion of the vitreoretinal disorder market.
How Is The Vitreoretinal Disorder Market Structured Across Different Segments?
The vitreoretinal disorder market covered in this report is segmented –
1) By Type: Retinal Tear, Retinal Detachment, Diabetic Retinopathy, Macular Degeneration, Macular Hole, Other Types
2) By Diagnosis: Digital Fluorescein Angiography, Optical Coherence Tomography, Heidelberg Retinal Tomography, Indocyanine Green Angiography, Other Diagnosis
3) By Treatment: Surgery, Medication, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Retinal Tear: Atrophic Retinal Tear, Operculated Retinal Tear, Horseshoe Retinal Tear, Giant Retinal Tear
2) By Retinal Detachment: Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, Exudative Retinal Detachment
3) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema
4) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
5) By Macular Hole: Full-Thickness Macular Hole, Lamellar Macular Hole, Tractional Macular Hole
6) By Other Types: Epiretinal Membrane, Retinal Vein Occlusion, Retinal Artery Occlusion, Retinitis Pigmentosa, Uveitis, Vitreous Hemorrhage, Macular Edema, Central Serous Retinopathy, Proliferative Vitreoretinopathy
How Are Trends Impacting The Vitreoretinal Disorder Market?
Leading companies in the vitreoretinal disorder market are concentrating on advanced offerings like continuous delivery drug solutions to reduce the frequency of injections and enhance patient results. These continuous delivery drug solutions are medical systems that provide a sustained, controlled release of medication directly to the eye, thereby minimizing the need for frequent injections, maintaining consistent therapeutic levels, and improving patient adherence and visual outcomes. For example, in February 2025, Roche, a Switzerland-based global pharmaceutical company, secured U.S. Food and Drug Administration (FDA) approval for Susvimo (ranibizumab injection) 100 mg/mL, a Port Delivery System designed for diabetic macular edema (DME). Susvimo delivers continuous ranibizumab via a refillable implant, allowing patients to sustain vision with as few as two treatments per year, in contrast to the previous requirement for monthly eye injections. This system was evaluated during the Phase III Pagoda study, where it demonstrated sustained improvements in visual acuity and safety consistent with earlier approvals for neovascular age-related macular degeneration (nAMD). Susvimo’s innovative platform effectively lessens the treatment burden, boosts patient convenience, and addresses the increasing global prevalence of DME.
Which Major Players Dominate The Vitreoretinal Disorder Market?
Major companies operating in the vitreoretinal disorder market are F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Topcon Corporation, Carl Zeiss Meditec AG, Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Kodiak Sciences Inc., Clearside Biomedical, Apellis Pharmaceuticals Inc., Genentech Inc., Oxurion NV, Adverum Biotechnologies Inc., Opthea Limited, Graybug Vision Inc., Kiora Pharmaceuticals Inc., Allegro Ophthalmics Inc., Lineage Cell Therapeutics Inc., Ocugen Inc.
Read the full vitreoretinal disorder market report here:
https://www.thebusinessresearchcompany.com/report/vitreoretinal-disorder-global-market-report
Which Region Is Projected To Dominate The Vitreoretinal Disorder Market During The Forecast Period?
North America was the largest region in the vitreoretinal disorder market in 2025. The regions covered in the vitreoretinal disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Vitreoretinal Disorder Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23574&type=smp
Browse Through More Reports Similar to the Global Vitreoretinal Disorder Market 2026, By The Business Research Company
Retinal Disorder Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
Vitrectomy Devices Global Market Report
https://www.thebusinessresearchcompany.com/report/vitrectomy-devices-global-market-report
Optic Nerve Disorders Treatment Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model